In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Optimizing device therapy for arrhythmia
Session

Event : ESC Congress 2019

Topic : Device Therapy

  • Session type : Rapid Fire Abstracts
  • Date : 01 September 2019
  • Time : 18:40 - 19:50

8 presentations in this session

Experience with the wearable cardioverter-defibrillator by disease etiology: results from the wearit-II registry

Event : ESC Congress 2019

  • Session : Optimizing device therapy for arrhythmia
  • Speaker : V Kutyifa (Rochester,US)

The use of wearable cardioverter defibrillator in France

Event : ESC Congress 2019

  • Session : Optimizing device therapy for arrhythmia
  • Speaker : E Marijon (Paris,FR)

When do cardiac rhythm management device complications occur?

Event : ESC Congress 2019

  • Session : Optimizing device therapy for arrhythmia
  • Speaker : C Brough (Cheshire,GB)

Role of implantation access on complication rates in pacemaker implantation

Event : ESC Congress 2019

  • Session : Optimizing device therapy for arrhythmia
  • Speaker : KP Bestehorn (Zell,DE)

Influence of transvenous lead extraction procedure on function of tricuspid apparatus

Event : ESC Congress 2019

  • Session : Optimizing device therapy for arrhythmia
  • Speaker : A Polewczyk (Kielce,PL)

How can we improve the success of cardiac resynchronization therapy implantation?

Event : ESC Congress 2019

  • Session : Optimizing device therapy for arrhythmia
  • Speaker : A Nunes Ferreira (Lisboa,PT)

ALERT-CS - Development of an ECG-based cardiac syncope risk calculator

Event : ESC Congress 2019

  • Session : Optimizing device therapy for arrhythmia
  • Speaker : T Zimmermann (Basel,CH)

Oncologic radiotherapy-induced implantable cardioverter-defibrillator malfunctions: a real-time, in-vitro evaluation

Event : ESC Congress 2019

  • Session : Optimizing device therapy for arrhythmia
  • Speaker : E Di Girolamo (Chieti,IT)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are